Scientists have developed biosensors to detect SARS-CoV-2 proteins and antibodies in simulated nasal fluids and human sera, according to a study published in Nature...
Researchers at Children's Hospital of Philadelphia have developed a new gene therapy vector for blood disorders that is safer and more effective than those currently...
Using an engineered DNA therapeutic agent to silence transcription factor genes reduced myeloma stem cell abundance and increased the survival of mice bearing human...
A modification to CRISPR/Cas9 systems can improve their functionality for gene editing in DNA repair, according to a report published in Nature Communications on...
The first map of molecular responses of human lung cells to SARS-CoV-2 infection has been developed. It shows that the novel coronavirus causes significant protein...
One of the more puzzling aspects of the COVID-19 pandemic is the resistance of children to the negative effects of infection with the SARS-CoV-2 virus. A...
Similar safety and immunogenicity profiles were observed in adults and older adults who received the Oxford/AstraZeneca SARS-CoV-2 vaccine candidate, ChAdOx1 nCoV-19,...
Why do children seem to be more resistant to SARS-CoV-2 infection than adults? The answer may lie in the age-dependent presence of a key viral enzyme,...
Synthetic nanobodies may provide a practical avenue for the development of novel COVID-19 therapies compared to human antibodies, which are bulkier and require...
How long does the immune response last in patients with the SARS-CoV-2 virus? This has been a key question in shaping the public health response to...